Pulmonary Sarcoidosis Investigational Medication

Trial Objective

This research study evaluates an investigational medication called Acthar® Gel (Acthar) as a potential treatment of pulmonary sarcoidosis.

Pulmonary Sarcoidosis Investigational Medication

Enrollment

This trial is active and currently recruiting.

How to Participate

For more information, contact Carmen Egidio at 303.398.1708 or complete the form below.

Who Can Participate

People with biopsy-confirmed sarcoidosis for more than a year.


Estimated Time Commitment

Participants in the study inject the medication twice a week at home and have appointments every 4 weeks.

Study participants will need to fast prior to their visits. Visit lengths will vary.

Trial Location

National Jewish Main Campus, Denver, CO

Compensation

Provided

Trial Sponsors

Mallinckrodt Pharmaceuticals

Age

18-90


Gender

Any Gender

Principal Investigators


Request More Information

*
*
*
*